**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 36615-45-9 |Tosylmethyl Isocyanide | ca100 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 23/24/25
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if swallowed.Moisture
sensitive.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be absorbed through the skin in harmful
amounts. May be metabolized to cyanide which in turn acts by
inhibiting cytochrome oxidase impairing cellular respiration.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with
nausea, vomiting and diarrhea. May cause cardiac disturbances. May
cause central nervous system depression. Ingestion may result in
symptoms similar to cyanide poisoning which is characterized by
asphyxiation.
Inhalation:
Causes respiratory tract irritation. May cause cardiac
abnormalities. Contains cyanide. Can produce delayed pulmonary edema.
May be metabolized to cyanide which in turns act by inhibiting
cytochrome oxidase impairing cellular respiration. Inhalation may
result in symptoms similar to cyanide poisoning which include
tachypnea, hyperpnea (abnormally rapid or deep breathing), and
dyspnea (labored breathing) followed rapidly by respiratory
depression. Pulmonary edema may occur. Inhalation at high
concentrations may cause CNS depression and asphixiation.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration. Effects may be
delayed. Chronic exposure to cyanide solutions may lead to the
development of a "cyanide" rash, characterized by itching, and by
macular, papular, and vesicular eruptions, and may be accompanied by
secondary infections. Exposure to small amounts of cyanide compounds
over long periods of time is reported to cause loss of appetite,
headache, weakness, nausea, dizziness, and symptoms of irritation of
the upper respiratory tract and eyes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively. May be partially metabolized
to cyanide in the body.
Antidote:
Always have a cyanide antidote kit on hand when working with cyanide
compounds. Get medical advice to use.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Containers
may explode when heated. Non-combustible, substance itself does not
burn but may decompose upon heating to produce corrosive and/or
toxic fumes. Runoff from fire control or dilution water may cause
pollution.
Extinguishing Media:
Do NOT get water inside containers. Use water spray, dry chemical,
carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Provide ventilation. Do not get water inside containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid contact with eyes, skin, and clothing. Keep container tightly
closed. Avoid ingestion and inhalation. Use with adequate
ventilation. Do not allow contact with water. Wash clothing before
reuse. Keep from contact with moist air and steam.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Keep
refrigerated. (Store below 4C/39F.) Store protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 36615-45-9:
Personal Protective Equipment
Eyes:
Wear safety glasses and chemical goggles if splashing
is possible.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: slightly yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 114.00 - 115.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: insoluble
Specific Gravity/Density:
Molecular Formula: C9H9NO2S
Molecular Weight: 195.24
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. May decompose on exposure to moist air or
water.
Conditions to Avoid:
Incompatible materials, dust generation, moisture, excess heat.
Incompatibilities with Other Materials:
Moisture, oxidizing agents, strong acids.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide,
cyanide fumes, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 36615-45-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Tosylmethyl Isocyanide -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 23/24/25 Toxic by inhalation, in contact with skin
and if swallowed.
Safety Phrases:
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 36615-45-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 36615-45-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 36615-45-9 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Acetophenone, 99%
| 98-86-2 |
|
N-Ethyl-N-Hydroxyethylaniline, 96%
| 92-50-2 |
|
2-Amino-2-ethyl-1,3-propanediol, 97%
| 115-70-8 |
|
Acetyl chloride, p.a.
| 75-36-5 |
|
o-Benzylhydroxylamine hydrochloride,99%
| 2687-43-6 |
|
Bromocresol Purple, Water Soluble, Indicator Grade
| 62625-30-3 |
|
2-Bromoethylbenzene, 98%
| 1973-22-4 |
|
Ethyl (Z)-3-Bromo-2-Propenoate, 99%
| 31930-34-4 |
|
Calix[8]Arene, 97% (Elemental Analysis)
| 82452-93-5 |
|
D(+)-Camphoric acid, 99%
| 124-83-4 |
|
1,1'-Carbonyldiimidazole, 97%
| 530-62-1 |
|
Celatom FW-14
| 60676-86-0 |
|
Chalkone, 97%
| 94-41-7 |
|
4-Cyanophenol, 99%
| 767-00-0 |
|
Tetranitro Blue Tetrazolium Chloride Contains Ethanol of
| 1184-43-6 |
|
Cyclohexyl isocyanide, 99%
| 931-53-3 |
|
2,4-Dichlorobenzoic acid, 98%
| 50-84-0 |
|
2,4-Dichlorophenylacetic Acid, 99%
| 19719-28-9 |
|
3,4-Dimethoxyacetophenone, 98% (GC)
| 1131-62-0 |
|
2,3-Dimethoxybenzoic Acid, 99%
| 1521-38-6 |
|
Dimethyl isophthalate (Pract)
| 1459-93-4 |
|
1,2-Diphenylhydrazine 97%
| 122-66-7 |
|
Dl-Norleucine, 98%
| 616-06-8 |
|
1-(4-Methoxyphenyl)Piperazine, 96% (GC)
| 38212-30-5 |
|
Ethyl 2-Amino-4-Thiazoleacetate, 99%
| 53266-94-7 |
|
4-Fluoro-alpha-cyclopropyl-alpha--
| 427-53-2 |
|
2,4-Pentanedione, 99+%
| 123-54-6 |
|
Itaconic Acid, 99+%
| 97-65-4 |
|
N-Benzyl-N-Ethylaniline, 99+%
| 92-59-1 |
|
2,3-Dibromosuccinic acid, 95% (titr.)
| 526-78-3 |
|
Methyl 4-hydroxybenzoate, sodium salt, 99.0-102.0%
| 5026-62-0 |
|
Methyl 4-tert-butylbenzoate, 99%
| 26537-19-9 |
|
Trifluoroacetic Acid-D, 99.5 Atom % D
| 599-00-8 |
|
3-Nitrobenzaldehyde, 99%
| 99-61-6 |
|
2-Nitro-2-methyl-1,3-propanediol, 99%
| 77-49-6 |
|
l-2-Octanol, 99+%
| 5978-70-1 |
|
o-Nitrocinnamic acid, 97%, predominantly trans
| 612-41-9 |
|
Acetone-d6, 99.8 atom % D
| 666-52-4 |
|
3-Picolyl chloride hydrochloride, 99%
| 6959-48-4 |
|
Acacia
| 9000-01-5 |
|
Potassium Hydride, 20-25% wt.% Dispersion in Mineral Oil
| 7693-26-7 |
|
Propionaldehyde, 99+%
| 123-38-6 |
|
Trifluoroacetic Acid-D, Packaged in 1ml Ampules, 99.5 Atom % D
| 599-00-8 |
|
Nitromethane-d3, packaged in 1.00 ml ampules, 99 atom % D
| 13031-32-8 |
|
Sudan ii
| 3118-97-6 |
|
3Tert.-Butylamine, 99%
| 75-64-9 |
|
Tetrabutylammonium fluoride, 1M solution in THF, containing less than
| 109-99-9 |
|
Tetraphenylphosphonium Bromide, 99%
| 2751-90-8 |
|
Tosylmethyl Isocyanide, 98%
| 36615-45-9 |
|
9-Vinylanthracene
| 2444-68-0 |
|
|